Oxygen Biotherapeutics, Inc.
GPTKB entity
Statements (15)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:focus |
oxygen therapeutics
perfluorocarbon-based products |
| gptkbp:formerName |
gptkb:Biopure_Corporation
|
| gptkbp:founded |
1989
|
| gptkbp:headquartersLocation |
gptkb:Morrisville,_North_Carolina,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Oxygen Biotherapeutics, Inc.
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:product |
gptkb:Oxycyte
Dermacyte |
| gptkbp:renamed |
Tenax Therapeutics, Inc.
|
| gptkbp:tradedOn |
NASDAQ: OXBT
|
| gptkbp:website |
https://www.tenaxthera.com/
|
| gptkbp:bfsParent |
gptkb:Oxycyte
|
| gptkbp:bfsLayer |
8
|